BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1523 related articles for article (PubMed ID: 15893129)

  • 1. Alzheimer's disease and the 'ABSENT' hypothesis: mechanism for amyloid beta endothelial and neuronal toxicity.
    Roy S; Rauk A
    Med Hypotheses; 2005; 65(1):123-37. PubMed ID: 15893129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
    Henry-Feugeas MC
    Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrovascular disease and the pathophysiology of Alzheimer's disease. Implications for therapy.
    Weller RO; Cohen NR; Nicoll JA
    Panminerva Med; 2004 Dec; 46(4):239-51. PubMed ID: 15876980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo conversion of racemized beta-amyloid ([D-Ser 26]A beta 1-40) to truncated and toxic fragments ([D-Ser 26]A beta 25-35/40) and fragment presence in the brains of Alzheimer's patients.
    Kubo T; Nishimura S; Kumagae Y; Kaneko I
    J Neurosci Res; 2002 Nov; 70(3):474-83. PubMed ID: 12391608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress in vascular dementia and Alzheimer's disease: a common pathology.
    Bennett S; Grant MM; Aldred S
    J Alzheimers Dis; 2009; 17(2):245-57. PubMed ID: 19221412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity.
    Varadarajan S; Yatin S; Aksenova M; Butterfield DA
    J Struct Biol; 2000 Jun; 130(2-3):184-208. PubMed ID: 10940225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-accumulation of vascular endothelial growth factor with beta-amyloid in the brain of patients with Alzheimer's disease.
    Yang SP; Bae DG; Kang HJ; Gwag BJ; Gho YS; Chae CB
    Neurobiol Aging; 2004 Mar; 25(3):283-90. PubMed ID: 15123332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What is 'early onset dementia'?
    Miyoshi K
    Psychogeriatrics; 2009 Jun; 9(2):67-72. PubMed ID: 19604328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium dyshomeostasis and neurotoxicity of Alzheimer's beta-amyloid protein.
    Kawahara M; Negishi-Kato M; Sadakane Y
    Expert Rev Neurother; 2009 May; 9(5):681-93. PubMed ID: 19402778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma beta amyloid and cytokine profile in women with Alzheimer's disease.
    Baranowska-Bik A; Bik W; Wolinska-Witort E; Martynska L; Chmielowska M; Barcikowska M; Baranowska B
    Neuro Endocrinol Lett; 2008 Feb; 29(1):75-9. PubMed ID: 18283248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unifying concept for Alzheimer's disease, vascular dementia and normal pressure hydrocephalus - a hypothesis.
    Chakravarty A
    Med Hypotheses; 2004; 63(5):827-33. PubMed ID: 15488655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease.
    Fuentealba RA; Farias G; Scheu J; Bronfman M; Marzolo MP; Inestrosa NC
    Brain Res Brain Res Rev; 2004 Dec; 47(1-3):275-89. PubMed ID: 15572177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria DNA deletions in atherosclerotic hypoperfused brain microvessels as a primary target for the development of Alzheimer's disease.
    Aliyev A; Chen SG; Seyidova D; Smith MA; Perry G; de la Torre J; Aliev G
    J Neurol Sci; 2005 Mar; 229-230():285-92. PubMed ID: 15760652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial dysfunction: A potential therapeutic target for geriatric depression and brain amyloid deposition in Alzheimer's disease?
    Isingrini E; Desmidt T; Belzung C; Camus V
    Curr Opin Investig Drugs; 2009 Jan; 10(1):46-55. PubMed ID: 19127486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification of vascular dementia in the Cardiovascular Health Study Cognition Study.
    Lopez OL; Kuller LH; Becker JT; Jagust WJ; DeKosky ST; Fitzpatrick A; Breitner J; Lyketsos C; Kawas C; Carlson M
    Neurology; 2005 May; 64(9):1539-47. PubMed ID: 15883314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAGE, LRP-1, and amyloid-beta protein in Alzheimer's disease.
    Donahue JE; Flaherty SL; Johanson CE; Duncan JA; Silverberg GD; Miller MC; Tavares R; Yang W; Wu Q; Sabo E; Hovanesian V; Stopa EG
    Acta Neuropathol; 2006 Oct; 112(4):405-15. PubMed ID: 16865397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary beds are decreased in Alzheimer's disease, but not in Binswanger's disease.
    Kitaguchi H; Ihara M; Saiki H; Takahashi R; Tomimoto H
    Neurosci Lett; 2007 May; 417(2):128-31. PubMed ID: 17403574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
    Abdul HM; Calabrese V; Calvani M; Butterfield DA
    J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A vascular connection to Alzheimer's disease.
    Rhodin JA; Thomas T
    Microcirculation; 2001 Aug; 8(4):207-20. PubMed ID: 11528529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 77.